As expected, hTS/Ink4a/Arf−/− mice did not develop pancreatic neuroendocrine tumors (PanNET) as shown previously in hTS transgenic mice [10]. This evidence concerns the gene CDKN2A and pancreatic neuroendocrine tumor.